Target intelligence / Profile preview

Complement component 4 binding protein, alpha pseudogene 1 (C4BPAP1)

Target
C4BPAP1
Molecular classification
Other (Pseudogene; does not encode a functional protein in humans)
01

Overview

C4BPAP1 is a member of the regulator of complement activation (RCA) gene cluster that evolved from duplication of the C4BPA gene after the separation of rodent and primate lineages[3][5]. It is located approximately 20 kb downstream of the C4BPA gene and shares sequence homology with several exons of C4BPA. Sequence analyses show it possesses nine exon-like regions homologous to the functional gene but currently does not code for an active protein in humans—it is considered a pseudogene[3]. Historically, C4BPAP1 may once have encoded a protein with structural similarity to the C4b-binding protein alpha chain, yet it is now non-functional due to accumulated mutations and the absence of required regulatory elements[3][5]. Key points: - C4BPAP1 is not a therapeutic target, nor does it encode a receptor, transporter, enzyme, or functional protein in humans[3]. It should not be confused with the functional gene C4BPA, which plays an important role in complement regulation and is associated with immune and thrombotic diseases[1][5]. - C4BPAP1 is not associated with any drugs, biological functions, or disease mechanisms. There are no known biomarkers or safety concerns linked specifically to this pseudogene. If information about a functional protein target is needed, refer to C4BPA (complement component 4 binding protein, alpha), not C4BPAP1.

Other names
C4BPAP1C4BPAL1complement component 4 binding protein alpha pseudogene 1complement component 4-binding protein alpha-like 1

Beyond the preview

Go deeper on Complement component 4 binding protein, alpha pseudogene 1 (C4BPAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement component 4 binding protein, alpha pseudogene 1 (C4BPAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call